EpiBone
Hank currently serves as a Director of BioStar Ventures, a US based medical device venture capital fund. He also serves as a Board Director for several medical technology companies in both the public and private sectors. Prior to joining BioStar, Mr. Kucheman served as Chief Executive Officer of Boston Scientific.
This person is not in the org chart
This person is not in any offices
EpiBone
3 followers
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.